Login

Assessing Austria's IT Industry in Global Competition | Helmut Fallmann , CEO of Fabasoft AG 00:10:00

Share On Facebook Share On Twitter

Helmut Fallmann is Chairman-Mgmt Board/CEO/Founder at Fabasoft AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Breaking Barriers and Building Generational Wealth | Martin Cabrera Jr. - Chief Executive Officer of Cabrera Capital Markets
00:00:00
Development of a mobile system for managing type 1 diabetes - Eric Beard, Chairman and CEO of Cellnovo Group
00:10:00
Tax-Free Retirement: The Boundless Financial Solutions Navigator Plan
00:10:00
George W. Bush Reflects on Life After the Presidency and His Presidential Center
00:10:00
Stock News Now for Ascletis Pharma Inc. (HKEX: 1672) | Jinzi J. Wu, PhD , CEO, ASCLETIS PHARMA INC
00:10:00
Centaurus Metals: Expanding Copper-Gold and Nickel-Cobalt Projects in Brazil
00:10:00
David Solomon on Goldman Sachs' Strategic Moves Amid Crisis and Future Outlook | David Solomon, CEO, Goldman Sachs.
00:10:00
focuses on making life simpler and more affordable for our generation|Ankur Jain,Co-CEO,Kairos HQ
00:10:00
Marathoon Fund Management , Managing Director at Firefinch Limited
00:10:00
Connecting Canadian and Aboriginal Businesses for Economic Success
00:10:00
NRG Energy CEO Mauricio Gutierrez discusses promoting racial equality and the company's outlook on "Squawk on the Street."
00:10:00
Exclusive Interview: Hesai Talks AT128 Integration with Human Horizons CTO for HiPhi Z Luxury EV | Dr. Yifan "David" Li - Co-Founder & CEO of Hesai Group

© 2017 - Neuhu+